These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 14685154)

  • 41. [Role of cytokines and gene expression characteristics in cultured lymphocytes ex vivo for adoptive immunotherapy].
    Zhang GL; Tao XY; Liu ZL; Liu Y; Wang Z; Liu HX; Cai P; Bu DF; Guo XL; Zhu P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):184-8. PubMed ID: 21362248
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adoptive immunotherapy for EBV-associated malignancies.
    Gottschalk S; Heslop HE; Rooney CM
    Leuk Lymphoma; 2005 Jan; 46(1):1-10. PubMed ID: 15621775
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of cytokine and chemokine genes in Epstein-Barr virus-associated nasopharyngeal carcinoma: comparison with Hodgkin's disease.
    Beck A; Päzolt D; Grabenbauer GG; Nicholls JM; Herbst H; Young LS; Niedobitek G
    J Pathol; 2001 Jun; 194(2):145-51. PubMed ID: 11400141
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antitumor activity of EBV-specific T lymphocytes transduced with a dominant negative TGF-beta receptor.
    Foster AE; Dotti G; Lu A; Khalil M; Brenner MK; Heslop HE; Rooney CM; Bollard CM
    J Immunother; 2008 Jun; 31(5):500-5. PubMed ID: 18463534
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Retroviral transduction of a T cell receptor specific for an Epstein-Barr virus-encoded peptide.
    Orentas RJ; Roskopf SJ; Nolan GP; Nishimura MI
    Clin Immunol; 2001 Feb; 98(2):220-8. PubMed ID: 11161978
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adoptive T-cell therapy for Epstein-Barr virus-positive Hodgkin's disease.
    Huls MH; Rooney CM; Heslop HE
    Acta Haematol; 2003; 110(2-3):149-53. PubMed ID: 14583675
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Establishment of anti-Epstein-Barr virus (EBV) cellular immunity by adoptive transfer of virus-specific cytotoxic T lymphocytes from an HLA-matched sibling to a patient with severe chronic active EBV infection.
    Kuzushima K; Yamamoto M; Kimura H; Ando Y; Kudo T; Tsuge I; Morishima T
    Clin Exp Immunol; 1996 Feb; 103(2):192-8. PubMed ID: 8565299
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma.
    Diepstra A; Niens M; Vellenga E; van Imhoff GW; Nolte IM; Schaapveld M; van der Steege G; van den Berg A; Kibbelaar RE; te Meerman GJ; Poppema S
    Lancet; 2005 Jun 25-Jul 1; 365(9478):2216-24. PubMed ID: 15978930
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epstein Barr virus specific cytotoxic T lymphocytes expressing the anti-CD30zeta artificial chimeric T-cell receptor for immunotherapy of Hodgkin disease.
    Savoldo B; Rooney CM; Di Stasi A; Abken H; Hombach A; Foster AE; Zhang L; Heslop HE; Brenner MK; Dotti G
    Blood; 2007 Oct; 110(7):2620-30. PubMed ID: 17507664
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Establishment of cytotoxic T lymphocytes specific for autologous Epstein-Barr virus in HIV-infected patients: the feasibility study of EBV-specific immunotherapy for patients with EBV-associated lymphoma.
    Hansasuta P; Incomserb P; Buranapraditkun S; Bhattarakosol P
    J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S146-51. PubMed ID: 16083179
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunobiology and pathophysiology of Hodgkin lymphomas.
    Poppema S
    Hematology Am Soc Hematol Educ Program; 2005; ():231-8. PubMed ID: 16304386
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CD4(+) Epstein-Barr virus-specific cytotoxic T-lymphocytes from human umbilical cord blood.
    Sun Q; Burton RL; Pollok KE; Emanuel DJ; Lucas KG
    Cell Immunol; 1999 Aug; 195(2):81-8. PubMed ID: 10448007
    [TBL] [Abstract][Full Text] [Related]  

  • 54. EBV-induced human CD8+ NKT cells suppress tumorigenesis by EBV-associated malignancies.
    Yuling H; Ruijing X; Li L; Xiang J; Rui Z; Yujuan W; Lijun Z; Chunxian D; Xinti T; Wei X; Lang C; Yanping J; Tao X; Mengjun W; Jie X; Youxin J; Jinquan T
    Cancer Res; 2009 Oct; 69(20):7935-44. PubMed ID: 19808969
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bone marrow cells promote TH2 polarization and inhibit virus-specific CTL generation.
    Jin Y; Fuller L; Wei Y; Blomberg BB; Miller J; Esquenazi V
    Hum Immunol; 2000 Dec; 61(12):1233-41. PubMed ID: 11163078
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Administration of latent membrane protein 2-specific cytotoxic T lymphocytes to patients with relapsed Epstein-Barr virus-positive lymphoma.
    Bollard CM; Huls MH; Buza E; Weiss H; Torrano V; Gresik MV; Chang J; Gee A; Gottschalk SM; Carrum G; Brenner MK; Rooney CM; Heslop HE
    Clin Lymphoma Myeloma; 2006 Jan; 6(4):342-7. PubMed ID: 16507214
    [No Abstract]   [Full Text] [Related]  

  • 57. Improving T-cell therapy for relapsed EBV-negative Hodgkin lymphoma by targeting upregulated MAGE-A4.
    Cruz CR; Gerdemann U; Leen AM; Shafer JA; Ku S; Tzou B; Horton TM; Sheehan A; Copeland A; Younes A; Rooney CM; Heslop HE; Bollard CM
    Clin Cancer Res; 2011 Nov; 17(22):7058-66. PubMed ID: 21908573
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunotherapy of experimental metastases by vaccination with interleukin gene-transduced adenocarcinoma cells sharing tumor-associated antigens. Comparison between IL-12 and IL-2 gene-transduced tumor cell vaccines.
    Rodolfo M; Zilocchi C; Melani C; Cappetti B; Arioli I; Parmiani G; Colombo MP
    J Immunol; 1996 Dec; 157(12):5536-42. PubMed ID: 8955204
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficient antigen presentation to cytotoxic T lymphocytes by cells transduced with a retroviral vector expressing the HIV-1 Nef protein.
    Robertson MN; Buseyne F; Schwartz O; Rivière Y
    AIDS Res Hum Retroviruses; 1993 Dec; 9(12):1217-23. PubMed ID: 7511396
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional reversion of antigen-specific CD8+ T cells from patients with Hodgkin lymphoma following in vitro stimulation with recombinant polyepitope.
    Smith C; Cooper L; Burgess M; Rist M; Webb N; Lambley E; Tellam J; Marlton P; Seymour JF; Gandhi M; Khanna R
    J Immunol; 2006 Oct; 177(7):4897-906. PubMed ID: 16982932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.